CHEBI:6933 - midodrine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name midodrine
ChEBI ID CHEBI:6933
Definition An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective α-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C12H18N2O4
Net Charge 0
Average Mass 254.28230
Monoisotopic Mass 254.12666
InChI InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)
InChIKey PTKSEFOSCHHMPD-UHFFFAOYSA-N
SMILES COc1ccc(OC)c(c1)C(O)CNC(=O)CN
Roles Classification
Biological Role(s): alpha-adrenergic agonist
An agent that selectively binds to and activates alpha-adrenergic receptors.
sympathomimetic agent
A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Application(s): prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
alpha-adrenergic agonist
An agent that selectively binds to and activates alpha-adrenergic receptors.
sympathomimetic agent
A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
vasoconstrictor agent
Drug used to cause constriction of the blood vessels.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing midodrine (CHEBI:6933) has functional parent deglymidodrine (CHEBI:73248)
midodrine (CHEBI:6933) has functional parent glycinamide (CHEBI:42843)
midodrine (CHEBI:6933) has role α-adrenergic agonist (CHEBI:35569)
midodrine (CHEBI:6933) has role prodrug (CHEBI:50266)
midodrine (CHEBI:6933) has role sympathomimetic agent (CHEBI:35524)
midodrine (CHEBI:6933) has role vasoconstrictor agent (CHEBI:50514)
midodrine (CHEBI:6933) is a amino acid amide (CHEBI:22475)
midodrine (CHEBI:6933) is a aromatic ether (CHEBI:35618)
midodrine (CHEBI:6933) is a secondary alcohol (CHEBI:35681)
midodrine (CHEBI:6933) is conjugate base of midodrine(1+) (CHEBI:73243)
Incoming midodrine(1+) (CHEBI:73243) is conjugate acid of midodrine (CHEBI:6933)
IUPAC Name
rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
INNs Sources
midodrina WHO MedNet
midodrine WHO MedNet
midodrine ChemIDplus
midodrinum WHO MedNet
Synonyms Sources
(±)-2-amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide ChEBI
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol ChemIDplus
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide ChemIDplus
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid ChemIDplus
Manual Xrefs Databases
1803 DrugCentral
C07890 KEGG COMPOUND
D08220 KEGG DRUG
DB00211 DrugBank
GB1003659 Patent
HMDB0014356 HMDB
LSM-1815 LINCS
Midodrine Wikipedia
US3340298 Patent
View more database links
Registry Numbers Types Sources
2384653 Reaxys Registry Number Reaxys
2384653 Beilstein Registry Number Beilstein
42794-76-3 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
11096750 PubMed citation Europe PMC
15273244 PubMed citation Europe PMC
16676655 PubMed citation Europe PMC
17901021 PubMed citation Europe PMC
18410283 PubMed citation Europe PMC
18840368 PubMed citation Europe PMC
19522958 PubMed citation Europe PMC
20376815 PubMed citation Europe PMC
20844343 PubMed citation Europe PMC
21343575 PubMed citation Europe PMC
21801220 PubMed citation Europe PMC
22436941 PubMed citation Europe PMC
23051063 PubMed citation Europe PMC
Last Modified
22 February 2017